Your Search Results

Marian Kukucka

Berlin, Germany

Karel Van Praet

Berlin, Germany

Banafsheh Alimi

Helmstedt, Germany

Basel Alsabaten

Riyadh, Saudi Arabia

Aria Alimi

Hann. Münden, Germany

Rob Eerdekens

Eindhoven, Netherlands

Yongzhen Fan

Cardiology Department, China

Malcolm Finlay

London, United Kingdom

Kritika Iyer

University of Michigan, United States of America

Pierre Qian

NSW, Australia

Tamas Szucsborus

Szeged, Hungary

Hao Yang

Shanghai, China

Nathalie Noirclerc

Lausanne, Switzerland

Top 10 most cited 2021 articles in the Transcatheter Tricuspid field

11 Jan 2022

A. Sticchi and J. Curio provide you with a summary of the studies that highlighted 2021 in the field of transcatheter tricuspid intervention: TRILUMINATE, CLASP TR EFS, EVOQUE TTVR, TRI-REPAIR, and more.

Robocath concludes first European clinical study to demonstrate safety and efficacy of robotic coronary angioplasty performed with R-One

12 Jan 2022

Cunnington Michael

Leeds, United Kingdom

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results

21 Jan 2022

The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.